Ameriprise’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-15,330
Closed -$28K 4055
2022
Q2
$28K Sell
15,330
-1,405
-8% -$2.57K ﹤0.01% 3845
2022
Q1
$34K Buy
16,735
+1,405
+9% +$2.85K ﹤0.01% 3886
2021
Q4
$42K Sell
15,330
-2,135
-12% -$5.85K ﹤0.01% 3906
2021
Q3
$78K Sell
17,465
-1,430
-8% -$6.39K ﹤0.01% 3797
2021
Q2
$109K Buy
18,895
+2,220
+13% +$12.8K ﹤0.01% 3813
2021
Q1
$117K Buy
+16,675
New +$117K ﹤0.01% 3755
2020
Q4
Sell
-16,222
Closed -$94K 3846
2020
Q3
$94K Buy
16,222
+360
+2% +$2.09K ﹤0.01% 3643
2020
Q2
$107K Sell
15,862
-6,030
-28% -$40.7K ﹤0.01% 3577
2020
Q1
$139K Buy
+21,892
New +$139K ﹤0.01% 3493
2019
Q3
Sell
-48,313
Closed -$721K 3774
2019
Q2
$721K Sell
48,313
-211,076
-81% -$3.15M ﹤0.01% 3185
2019
Q1
$6.44M Buy
259,389
+209,429
+419% +$5.2M ﹤0.01% 2056
2018
Q4
$896K Sell
49,960
-41,313
-45% -$741K ﹤0.01% 2978
2018
Q3
$2.68M Sell
91,273
-403,171
-82% -$11.8M ﹤0.01% 2695
2018
Q2
$22.5M Sell
494,444
-358,507
-42% -$16.3M 0.01% 1093
2018
Q1
$45M Buy
852,951
+377,073
+79% +$19.9M 0.02% 714
2017
Q4
$32.4M Sell
475,878
-5,616
-1% -$382K 0.01% 783
2017
Q3
$39.7M Buy
481,494
+62,730
+15% +$5.17M 0.02% 651
2017
Q2
$39.2M Buy
418,764
+70,927
+20% +$6.64M 0.02% 641
2017
Q1
$22.1M Buy
347,837
+315,543
+977% +$20.1M 0.01% 948
2016
Q4
$1.43M Sell
32,294
-42,601
-57% -$1.89M ﹤0.01% 2789
2016
Q3
$2.7M Buy
+74,895
New +$2.7M ﹤0.01% 2405
2015
Q4
Sell
-127,484
Closed -$11.7M 3916
2015
Q3
$11.7M Buy
127,484
+24,126
+23% +$2.22M 0.01% 1339
2015
Q2
$9.08M Sell
103,358
-155,694
-60% -$13.7M 0.01% 1679
2015
Q1
$19.2M Sell
259,052
-178,457
-41% -$13.2M 0.01% 1036
2014
Q4
$24.5M Buy
437,509
+373,654
+585% +$20.9M 0.01% 843
2014
Q3
$2.9M Buy
63,855
+59,585
+1,395% +$2.7M ﹤0.01% 2344
2014
Q2
$177K Sell
4,270
-118,272
-97% -$4.9M ﹤0.01% 3375
2014
Q1
$8.49M Buy
122,542
+116,927
+2,082% +$8.1M 0.01% 1645
2013
Q4
$338K Sell
5,615
-9,557
-63% -$575K ﹤0.01% 2977
2013
Q3
$921K Buy
15,172
+14,271
+1,584% +$866K ﹤0.01% 2712
2013
Q2
$60K Buy
+901
New +$60K ﹤0.01% 3620